This issue marks the beginning of the second year in the life of *Mayo Clinic Proceedings: Innovations, Quality & Outcomes* (*MCP:IQ&O*). This is a good time to reflect on what goals we have achieved, and what strategies might help us take the journal to the next level.

By all criteria for a new online-only, open-access journal, *MCP:IQ&O* is doing exceptionally well. Since we opened the journal for submissions in February of 2017, we have processed 110 manuscripts and have published 71 articles (including 14 articles in the current issue). In keeping with our stated intent of expanding the scope of clinically focused information published under the *Mayo Clinic Proceedings* (*MCP*) brand,[@bib1] the articles published in *MCP:IQ&O* have covered a broad spectrum of topics spanning from medicine[@bib2] over medical education[@bib3] to preliminary reports of new diagnostic techniques.[@bib4] Reflecting *MCP:IQO*'s mission statement of "building upon *innovations* in research, advancing the *quality* of medical and surgical care, and promoting optimal patient *outcomes,*" the published material has unfailingly addressed the domains of innovations,[@bib5] quality,[@bib6] and outcomes[@bib7] across this wide range of topics.

Of course, publishing even the best content is in vain if the content has no audience. In this regard, the editors are very happy with the attention our journal is receiving from readers in many different countries. As of May 1, 2018, our website has had more than 13,000 page views from almost 6500 unique visitors from all over the world, including North America, South America, Asia, Europe, Africa, and Australia. As of this writing (late July 2018), the most frequently read articles addressed improving patient care experience by directing attention to hiring, training, and developing clinical and nonclinical-support services,[@bib8] outcomes and predictors of mortality in acute alcoholic hepatitis based on data from a large prospective multicenter observational study,[@bib9] and developing a clinical decision support tool for familial hypercholesterolemia based on physician input.[@bib10]

Sincere thanks are due to all who have contributed to our success. Our parent journal *MCP* is currently the main source of submissions to *MCP:IQ&O*. Among the articles published in *MCP:IQ&O* over the last year, 83% were referred from *MCP*. The manuscripts referred to us from *MCP*, with or without reviews, are typically referred because they are a better editorial fit for *MCP:IQ&O*'s aims and scope, not because of concerns about their quality or validity. In keeping with the high standards for referral, the acceptance rate for manuscripts referred to us from *MCP* is nearly 100%. We are very grateful to the leadership of *MCP*, in particular its editor-in-chief, Dr Karl Nath, for the thoughtfulness and extra effort that the referral process requires. We are also extremely grateful to the entire editorial board of *MCP* who, to help jumpstart *MCP:IQ&O*, volunteered to serve in double duty as the editorial board for our journal for the first year. Here, we acknowledge with gratitude Dr Lori Erickson, who has agreed to continue as deputy editor of *MCP: IQ&O* beyond its first year of publication. We are also exceedingly grateful to the *MCP* editorial staff, who are regularly going above and beyond the call of duty to ensure that the coordination between *MCP* and *MCP:IQO* and the manuscript referral process run smoothly and expeditiously. Finally, our publisher Elsevier is providing invaluable guidance for *MCP:IQ&O* based on its track record in publishing leadership and its insights in, experience with, and practice of operating open-access journals.

Our priorities for the next year will build on our successes over the last year. We will continue to judiciously assemble a separate editorial board for *MCP: IQ&O* that reflects our previously stated mission, to include experts from fields not traditionally covered by *MCP*. The main task of the editorial team of *MCP:IQ&O* will be to not only uphold the high standards of acceptance for publication in *MCP:IQ&O* but also to help with increasing the proportion of direct submissions to *MCP:IQ&O* by attracting, recruiting, and contributing manuscripts that relate to their areas of expertise.

We do not anticipate, at this point, major changes to *MCP:IQ&O*'s current operating procedures,[@bib1] which aim to provide benefit to authors everywhere by seamless integration with *MCP* and a competitive timeline from submission to publication. No affiliation with Mayo Clinic is required to interact with *MCP:IQO*. The journal remains open to submissions from authors everywhere through our manuscript submission portal at ScholarOne (<https://mc.manuscriptcentral.com/mcpiqo>).[@bib11] Direct submissions to *MCP:IQ&O* should be prepared to the *MCP:IQ&O* Instructions for Authors.[@bib12] The journal endorses the health research reporting guidelines promulgated by the "Enhancing the QUAlity and Transparency Of Health Research" (EQUATOR)[@bib13] network, and we encourage authors to adhere, while preparing their manuscript, to the EQUATOR network guidelines pertinent to the article category of their submission. Note, too, that the journal adheres to the ICMJE guidelines on all ethical issues.

Your comments and inquiries about potential topics and articles may be directed to me at <mcpiqo@gmail.com>. The journal is looking forward to another year of serving our authors and readers.
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